Clinical Study Of Nearsightedness; TReatment With Orthokeratology Lenses (CONTROL)
Orthokeratology Contact Lenses for the Treatment of Myopia in a Group of Danish Children
1 other identifier
interventional
60
1 country
1
Brief Summary
Myopia is a common disease of the eye with increasing prevalence in the Western World as well as in South East Asia where 60-90% of the children are affected. High myopia is associated with an increasing risk of sight threatening complications such as retinal detachment, glaucoma, macular choroidal degeneration and myopic choroidal neovascularization. In myopia the eye is elongated compared to an emmetropic eye. If the elongation of the eye can be controlled the progression of myopia can be controlled. Asian studies have shown reduction in axial length growth by 36-46% in children using orthokeratology contact lenses (OKL). OKL are custom fit, form stable lenses. During sleep the cornea is reshaped creating an emmetropic vision during the day, so no glasses or contact lenses are needed. Twin and family studies have shown a high heritability for the development of myopia, and more than 40 genetic loci have been identified indicating that the effect of OKL in Asian children might not be the same in North European children which is why we want to execute a similar study on North European children. Purpose:
- 1.Investigate if nightly wear of OKL reduces the progression of childhood myopia (change in axial length) in Danish children when compared to a control group using monofocal glasses.
- 2.Investigate the safety (Efron score) of OKL.
- 3.Investigate children's quality of life impact of refractive correction (questionnaire) using OKL compared to glasses.
- 4.Identify possible predictors for progression of myopia (AC/A ratio, peripheral defocus and higher order aberrations).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2017
CompletedFirst Submitted
Initial submission to the registry
July 11, 2017
CompletedFirst Posted
Study publicly available on registry
August 11, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 17, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 17, 2020
CompletedMay 28, 2020
May 1, 2020
3.1 years
July 11, 2017
May 27, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Progression of myopia defined as change in axial length 18 months after start of intervention
Follow up to 18 months
Secondary Outcomes (3)
Quality of life comparison between myopic children wearing glasses and orthokeratology lenses using the Pediatric Refractive Error Profile 2 Questionnaire
Follow up to 18 months
Safety evaluation by Efron scores for orthokeratology lenses
Follow up to 18 months
Accommodation and higher-order aberrations
Follow up to 18 months
Study Arms (2)
Single-vision spectacles
PLACEBO COMPARATOROrthokeratology lenses
ACTIVE COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- Myopia -0.5 to -4.75 dioptries spherical in one or both eyes.
- Regular astigmatism ≤ -2.5 diopters in one or both eyes.
- Age 6 ≥ 12 years.
- Anisometropia \< 1.5 D spherical equivalent.
- Best corrected visual acuity of 0.1 logMAR or better in both eyes.
- Acceptance of treatment randomization.
You may not qualify if:
- Manifest or latent squint.
- Contraindications to the use of OKL comprising keratoconus, allergic conjunctivitis and keratoconjunctivitis sicca.
- Previous eye surgery.
- Chronic eye disease demanding daily use of eye drops.
- Non-compliance to eye examinations (unstable fixation or intolerance to OKL).
- One or both parents being ethnical Asian, African, Hispanic or Spanish.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Vejle Hospitallead
- Ens Eyescollaborator
Study Sites (1)
Vejle Hospital
Vejle, Jylland, 7100, Denmark
Related Publications (1)
Cerullo C, Moller F, Ewan R, Norgaard B, Jakobsen TM. Vision-related quality of life in children: Cross-cultural adaptation and test-retest reliability of the Danish version of the paediatric refractive error profile 2. Acta Ophthalmol. 2024 Sep;102(6):e970-e983. doi: 10.1111/aos.16685. Epub 2024 Apr 13.
PMID: 38613420DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 11, 2017
First Posted
August 11, 2017
Study Start
March 1, 2017
Primary Completion
April 17, 2020
Study Completion
April 17, 2020
Last Updated
May 28, 2020
Record last verified: 2020-05
Data Sharing
- IPD Sharing
- Will not share
IPD is not to be shared with other researchers.